Where we are with community-associated Staphylococcus aureus prevention-And in the meantime, what do we tell our patients?

Clinical Infectious Diseases

Volumn 54, Issue 6, 2012, Pages 752-754

  Miller, Loren G ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BLEACHING; DECOLONIZATION; HOUSEHOLD; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOTE; PATIENT EDUCATION; PRIORITY JOURNAL; SKIN AND SOFT TISSUE INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

CARRIER STATE; FAMILY CHARACTERISTICS; FEMALE; HUMANS; MALE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84857618973     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir922     Document Type: Note

References (13)

1. Miller LG, Kaplan SL. Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am 2009; 23:35-52.
2. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA. and Participants in the CDCConvened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available at: http://cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA-ExpMtgStrategies.pdf. Accessed 22 May 2006.
3. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168:1585-91.
4. Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009; 15:1516-18.
5. Graber CJ, Jacobson MA, Perdreau- Remington F, Chambers HF, Diep BA. Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr 2008; 49:231-3.
6. Fritz SA, Hogan PG, Hayek G, et al. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis 2011; 54:743-51.
7. Zafar U, Johnson LB, Hanna M, et al. Prevalence of nasal colonization among patients with community-associated methicillinresistant Staphylococcus aureus infection and their household contacts. Infect Control Hosp Epidemiol 2007; 28:966-9. (Pubitemid 47218277)
8. Miller LG, Diep BA. Colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:742-50.
9. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis 2009; 49:935-41.
10. Wang JT, Sheng WH, Wang JL, et al. Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Antimicrob Chemother 2008; 62:514-17.
11. Kaiser N, Klein D, Karanja P, Greten Z, Newman J. Inactivation of chlorhexidine gluconate on skin by incompatible alcohol hand sanitizing gels. Am J Infect Control 2009; 37:569-73.
12. Molnlycke Health Care. http://www. hibigeebies.com/ Accessed 24 October 2011.
13. Mozzillo KL, Ortiz N, Miller LG. Patients with methicillin-resistant Staphylococcus aureus infection: twenty-first century lepers. J Hosp Infect 2010; 75:132-4.